Page 2 - Cell Genesys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Juha Punnonen, M D , Ph D Joins Hinge Bio as Chief Development Officer

/PRNewswire/ Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company as Chief.

Carin rollinsJuha punnonenBarry selickBiosciences labcorpUniversity of turkuOncology leadership team at merck co incResearch instituteDevelopment officerStategics incSafety management teamProduct development teamMerck research labsPrnewswire hinge bio incBio incHuman immunology departmentHead of biology pharmacology at maxygen inc

Adaptimmune Announces Changes to Board of Directors

Adaptimmune Announces Changes to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoKristenm hegeAdrian rawcliffeBristol myers squibbDavid mottJulip millerDana lynchUniversity of californiaSchool of medicineCell genesys incDartmouth collegeMersana therapeutics incEarly clinical developmentGraphite bio incExchange commission

Adaptimmune Therapeutics (ADAP) Announces Board Changes

Adaptimmune Therapeutics (ADAP) Announces Board Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoKristenm hegeBristol myers squibbDavid mottAdrian rawcliffeUniversity of californiaSchool of medicineCell genesys incDartmouth collegeEarly clinical developmentMersana therapeutics incGraphite bio incFred hutchinson cancer research centerTal zaksNon executive director

Ambrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph D as Head of Cl

SAN DIEGO (BUSINESS WIRE) Ambrx Biopharma, Inc., or Ambrx (NYSE: AMAM), a clinical stage biopharmaceutical company using its proprietary Engineered Precision Biologics (EPBs) platform to create antibody-drug conjugates (ADCs), has appointed Sandra Aung, Ph.D., as Executive Vice President, Head of Clinical Developm.

Mike moyerSandra aungDaniel oconnorMike tattoryBiologics epbsNational cancer institute institutes of healthScripps research instituteCell genesys incAmbrx biopharma incHead of clinical developmentUbivac incLifesci communicationsSmall business innovate researchVanderbilt universityAmbrx biopharmaEngineered precision biologics

Hinge Bio Expands Senior Management Team to Drive

Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge.

United statesVillanova schoolSan franciscoBarry selickCarin rollinsBiosciences labcorpSelina husain robert flammJoshua carleHarolde barry selickUniversity of californiaDaiichi sankyo incClearview projects incBurns mcclellan incBio incBusiness development at triumvira immunologics incPfizer inc